@article{62117f6110bd4fefa86126ed5e87332f,
title = "Direct oral anticoagulants: a review on the current role and scope of reversal agents",
keywords = "Andexanet alfa, Apixaban, Betrixaban, DOACs, Dabigatran, Edoxaban, Idarucizumab, Reversal, Rivaroxaban",
author = "Rahul Chaudhary and Tushar Sharma and Jalaj Garg and Ajaypaul Sukhi and Kevin Bliden and Udaya Tantry and Mohit Turagam and Dhanunjaya Lakkireddy and Paul Gurbel",
note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2020",
month = feb,
day = "1",
doi = "10.1007/s11239-019-01954-2",
language = "English",
volume = "49",
pages = "271--286",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
number = "2",
}